Streetbeat News

Analyst Ratings

PYPL

Financial giants are making bearish moves on PayPal Holdings (NASDAQ:PYPL) through options trading. Analysis shows 60% bearish sentiment with significant trades in a price range of $57.5 to $100.0. The stock is currently down 1.86% at $76.13, with mixed analyst ratings.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:33 pm

JPM

Deep-pocketed investors are showing a bearish sentiment towards JPMorgan Chase (NYSE:JPM) with 70% of options activity being bearish. The options activity is unusually high, indicating potential significant market movements. Analysts have mixed ratings, with Morgan Stanley maintaining an Overweight rating and Deutsche Bank downgrading to Hold.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 4:32 pm

VST

BMO Capital analyst James Thalacker maintains an Outperform rating on Vistra (NYSE:VST) and raises the price target from $120 to $125.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:31 pm

RIGL

Cantor Fitzgerald analyst Kristen Kluska has reiterated a Neutral rating for Rigel Pharmaceuticals (NASDAQ:RIGL) and maintained a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:30 pm

FDS

BMO Capital has maintained a Market Perform rating on FactSet Research Systems and raised its price target from $440 to $471.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:30 pm

CRBP

Corbus Pharmaceuticals Holdings shares are trading lower in sympathy with Novo Nordisk after Novo's Phase2a trial results for Monlunabant in obesity. Wedbush maintained an Outperform rating on Corbus but lowered its price target from $85 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:29 pm

SLNO

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Soleno Therapeutics (NASDAQ:SLNO) and maintained a price target of $67.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:28 pm

DRI

BMO Capital analyst Andrew Strelzik maintains a Market Perform rating on Darden Restaurants and raises the price target from $165 to $175.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:27 pm

RARE

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) and maintained a price target of $116.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:27 pm

ELAN

Elanco Animal Health's shares are declining following a William Blair analyst's concerns about the efficacy and label warnings of its dermatology treatment for itchy dogs.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 4:26 pm